Roberto
Barriales Villa
Azienda Ospedaliero-Universitaria Careggi
Florencia, ItaliaPublicaciones en colaboración con investigadores/as de Azienda Ospedaliero-Universitaria Careggi (11)
2024
2023
-
Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy
Journal of the American College of Cardiology, Vol. 81, Núm. 1, pp. 34-45
2022
-
Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy
Journal of the American College of Cardiology, Vol. 79, Núm. 20, pp. 1986-1997
-
Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry
ESC Heart Failure, Vol. 9, Núm. 4, pp. 2189-2198
-
The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy
European Journal of Preventive Cardiology, Vol. 29, Núm. 4, pp. 645-653
2021
-
Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week
Journal of the American College of Cardiology, Vol. 77, Núm. 7, pp. 922-936
-
Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry
ESC Heart Failure, Vol. 8, Núm. 1, pp. 95-105
2020
-
Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis
Journal of the American College of Cardiology, Vol. 76, Núm. 2, pp. 186-197
-
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet, Vol. 396, Núm. 10253, pp. 759-769
2019
-
Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids)
JAMA Cardiology, Vol. 4, Núm. 9, pp. 918-927
2016
-
European cardiomyopathy pilot registry: EURObservational research programme of the European society of cardiology
European Heart Journal, Vol. 37, Núm. 2, pp. 164-173